Low Expression of GLIS2 Gene Might Associate with Radiosensitivity of Gastric Cancer

Abstract EN

Human gene GLIS family zinc finger 2 (GLIS2) is a member of GLI-similar zinc finger protein family.

Previous studies indicated GLIS2 gene involved in tumorigenesis mechanisms.

However, the association between GLIS2 expression and radiosensitivity of gastric cancer has not been well understood.

In this study, we used the gastric cancer database in TCGA, and significant association was observed between the low expression of GLIS2 and radiosensitivity of patients with gastric cancer.

The adjusted HR values for radiotherapy were 0.162(0.035-0.756) and 0.089(0.014-0.564), with p values 0.021 and 0.010, respectively, in training and testing data, for these patients with low expression of GLIS2, while for patients with high expression of GLIS2, there was no significant survival difference between radiotherapy and nonradiotherapy groups.

The adjusted HR were 0.676(0.288-1.586) and 0.508(0.178-1.450), with p values 0.368 and 0.206 in training and testing data, respectively.

Further study showed that, for low expression patients, radiotherapy did not significantly increase new tumor event rate and disease progression rate, which partially supported our assumption.

These results suggested that low expression of GLIS2 might significantly associate with the radiosensitivity of patients with gastric cancer.

The GLIS2 gene might be a potential effective molecular marker of gastric cancer for precise radiotherapy.